Company Filing History:
Years Active: 2022-2023
Title: Martin Kunze: Innovator in RNA Technology
Introduction
Martin Kunze is a notable inventor based in Rottenburg, Germany. He has made significant contributions to the field of RNA technology, holding three patents that showcase his innovative approaches to RNA molecule compositions and capping methods. His work has implications for pharmaceutical applications, particularly in the development of medicaments.
Latest Patents
One of Kunze's latest patents is a method for producing RNA molecule compositions. This invention relates to a method for producing a ribonucleic acid (RNA) molecule composition comprising different RNA molecule species. The method includes a step of RNA in vitro transcription of a mixture of various deoxyribonucleic acid (DNA) molecule species in a single reaction vessel simultaneously, followed by a step of obtaining the RNA molecule composition. Additionally, the invention provides the RNA composition and a pharmaceutical composition for use as a medicament.
Another significant patent by Kunze is a method for adding cap structures to RNA using immobilized enzymes. This invention involves an immobilized capping enzyme, preferably an immobilized Vaccinia virus capping enzyme. It also includes an immobilized cap-specific nucleoside 2'-O-methyltransferase. The invention outlines methods for immobilizing these enzymes and using them to add a 5'-cap structure to RNAs. Furthermore, it describes an enzyme reactor for performing the capping reaction and a kit comprising the capping enzyme and/or the cap-specific nucleoside 2'-O-methyltransferase.
Career Highlights
Throughout his career, Martin Kunze has worked with prominent companies in the biotechnology sector, including CureVac SE and CureVac AG. His experience in these organizations has allowed him to develop and refine his innovative techniques in RNA technology.
Collaborations
Kunze has collaborated with notable colleagues such as Benyamin Yazdan Panah and Tilmann Roos. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Martin Kunze is a distinguished inventor whose work in RNA technology has the potential to impact the pharmaceutical industry significantly. His innovative methods and collaborations highlight his commitment to advancing scientific knowledge and applications in this vital field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.